0
Your cart

Your cart is empty

Books > Medicine > General issues > Public health & preventive medicine > Epidemiology & medical statistics

Buy Now

Theory of Drug Development (Hardcover, New) Loot Price: R2,683
Discovery Miles 26 830
Theory of Drug Development (Hardcover, New): Eric B. Holmgren

Theory of Drug Development (Hardcover, New)

Eric B. Holmgren

Series: Chapman & Hall/CRC Biostatistics Series

 (sign in to rate)
Loot Price R2,683 Discovery Miles 26 830 | Repayment Terms: R251 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Theory of Drug Development presents a formal quantitative framework for understanding drug development that goes beyond simply describing the properties of the statistics in individual studies. It examines the drug development process from the perspectives of drug companies and regulatory agencies. By quantifying various ideas underlying drug development, the book shows how to systematically address problems, such as: Sizing a phase 2 trial and choosing the range of p-values that will trigger a follow-up phase 3 trial Deciding whether a drug should receive marketing approval based on its phase 2/3 development program and recent experience with other drugs in the same clinical area Determining the impact of adaptive designs on the quality of drugs that receive marketing approval Designing a phase 3 pivotal study that permits the data-driven adjustment of the treatment effect estimate Knowing when enough information has been gathered to show that a drug improves the survival time for the whole patient population Drawing on his extensive work as a statistician in the pharmaceutical industry, the author focuses on the efficient development of drugs and the quantification of evidence in drug development. He provides a rationale for underpowered phase 2 trials based on the notion of efficiency, which leads to the identification of an admissible family of phase 2 designs. He also develops a framework for evaluating the strength of evidence generated by clinical trials. This approach is based on the ratio of power to type 1 error and transcends typical Bayesian and frequentist statistical analyses.

General

Imprint: Crc Press
Country of origin: United States
Series: Chapman & Hall/CRC Biostatistics Series
Release date: October 2013
First published: 2013
Authors: Eric B. Holmgren
Dimensions: 234 x 156 x 22mm (L x W x T)
Format: Hardcover
Pages: 261
Edition: New
ISBN-13: 978-1-4665-0746-3
Categories: Books > Science & Mathematics > Biology, life sciences > General
Books > Medicine > General issues > Public health & preventive medicine > Epidemiology & medical statistics
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 1-4665-0746-2
Barcode: 9781466507463

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners